Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with breast cancer: results from an interim analysis of the non-interventional study NADIR.

Fietz, T., Kurbacher, C.M., Trarbach, T., Salat, C., Rezai, M., Lorenz, A., Niemeier, B., 2016.

Oncol Res Treat 39 (suppl3)(P952), 293. doi:10.1159/000449050

Studie: NADIR; Indikation: Mammakarzinom; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0